This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CGH | Ann: Completion of Buy Back and Delisting | 31/12/15 | 1 | 1.4K | |||
|
|||||||
CGH | Ann: Appendix 3F - Buy Back | 31/12/15 | 0 | 434 | |||
|
|||||||
CGH | Ann: Removal from Official List (close of trade 31 December 2015) | 24/12/15 | 0 | 534 | |||
|
|||||||
CGH | Delisting | 22/12/15 | 29 | 11K | |||
|
|||||||
CGH | Ann: Calibre - Buy Back Offer Book | 19/12/15 | 3 | 1.4K | |||
|
|||||||
CGH | Ann: Calibre Group New Directors | 18/12/15 | 0 | 409 | |||
|
|||||||
CGH | Ann: Appendix 3Y - Peter Reichler | 04/12/15 | 0 | 343 | |||
|
|||||||
CGH | Ann: Calibre Group Transport executive resignation | 04/12/15 | 0 | 325 | |||
|
See All Discussions